Previous 10 | Next 10 |
The law firm of Kirby McInerney LLP is investigating potential claims against Inotiv, Inc. (“Inotiv” or the “Company”) (NASDAQ: NOTV ). The investigation concerns whether Inotiv has violated the federal securities laws and/or engaged in other unlawful...
Gainers: Lixiang Education Holding (LXEH) +62%. GeoVax Labs (GOVX) +50%. Sonder Holdings (SOND) +30%. O2Micro International (OIIM) +30%. Evolving Systems (OTC:EVOL) +28%. GoldMining (GLDG) +27%. Neonode (NEON) +24%. Mesa Royalty Trust (MTR) +24%. TRxADE HEALTH (MEDS) +23%. Losers: HIVE Blockc...
Life sciences company, Inotiv (NASDAQ:NOTV) has lost ~18% on Monday, the most since September, after announcing that the U.S. Department of Justice initiated legal action against one of its subsidiaries regarding alleged violations of animal welfare. The issues relate to a Cumberlan...
Inotiv (NASDAQ:NOTV) stock rose ~39% May 13 after Q2 results beat analysts' estimates a day ago and the company placed its FY22 revenue outlook above expectations. Q2 Revenue grew +646.3% Y/Y to $140.3M, driven by a $20.3M increase in DSA revenue and $101.2M of incremental RMS ...
Gainers: Inotiv (NOTV) +41%. TScan Therapeutics (TCRX) +23%. SomaLogic (SLGC) +19%. Veru (VERU) +18%. Celularity (CELU) +17%. Losers: Opiant Pharmaceuticals (OPNT) -16%. Renovacor (RCOR) -15%. Embecta (EMBC) -7%. Wave Life Sciences (WVE) -5%. ...
Inotiv, Inc. (NOTV) Q2 2022 Earnings Conference Call May 12, 2022 04:30 PM ET Company Participants Bob Leasure - President and Chief Executive Officer Beth Taylor - Chief Financial Officer Kalle Ahl - The Equity Group Conference Call Participants Frank Takkinen - Lake Street Capital Markets M...
Inotiv press release (NASDAQ:NOTV): Q2 GAAP EPS of -$0.24 beats by $0.03. Revenue of $140.31M (+648.3% Y/Y) beats by $19.75M. Book-to-bill ratio was 1.52x for the DSA services business for the three months ended March 31, 2022. DSA backlog was $133.6 million at March 31, 2022, up 27.7% compar...
WEST LAFAYETTE, Ind., May 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and dev...
WEST LAFAYETTE, Ind., April 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
The shares of the Medpace Holdings (NASDAQ:MEDP) have reached a 52-week low on Tuesday after the contract research organization set the 2022 outlook unchanged despite its 1Q 2022 financials that stood above Street forecasts. The peers in the subsector, including ICON (ICLR), IQVIA Holdin...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...